28901737|t|Melatonin Improves Cognitive Deficits via Restoration of Cholinergic Dysfunction in a Mouse Model of Scopolamine-Induced Amnesia.
28901737|a|Melatonin is known to improve cognitive deficits, and its functions have been studied in various disease models, including Alzheimer's disease. In this study, we investigated effects of melatonin on cognition and the cholinergic system of the septum and hippocampus in a mouse model of scopolamine-induced amnesia. Scopolamine (1 mg/kg) and melatonin (10 mg/kg) were administered intraperitoneally to mice for 2 and 4 weeks. The Morris water maze and passive avoidance tests revealed that both treatments of scopolamine significantly impaired spatial learning and memory; however, 2- and 4-week melatonin treatments significantly improved spatial learning and memory. In addition, scopolamine treatments significantly decreased protein levels and immunoreactivities of choline acetyltransferase (ChAT), high-affinity choline transporter (CHT), vesicular acetylcholine transporter (VAChT), and muscarinic acetylcholine receptor M1 (M1R) in the septum and hippocampus. However, the treatments with melatonin resulted in increased ChAT-, CHT-, VAChT-, and M1R-immunoreactivities and their protein levels in the septum and hippocampus. Our results demonstrate that melatonin treatment is effective in improving the cognitive deficits via restoration of the cholinergic system in the septum and hippocampus of a mouse model of scopolamine-induced amnesia.
28901737	0	9	Melatonin	Chemical	MESH:D008550
28901737	19	37	Cognitive Deficits	Disease	MESH:D003072
28901737	57	80	Cholinergic Dysfunction	Disease	MESH:C535672
28901737	86	91	Mouse	Species	10090
28901737	101	112	Scopolamine	Chemical	MESH:D012601
28901737	121	128	Amnesia	Disease	MESH:D000647
28901737	130	139	Melatonin	Chemical	MESH:D008550
28901737	160	178	cognitive deficits	Disease	MESH:D003072
28901737	253	272	Alzheimer's disease	Disease	MESH:D000544
28901737	316	325	melatonin	Chemical	MESH:D008550
28901737	401	406	mouse	Species	10090
28901737	416	427	scopolamine	Chemical	MESH:D012601
28901737	436	443	amnesia	Disease	MESH:D000647
28901737	445	456	Scopolamine	Chemical	MESH:D012601
28901737	471	480	melatonin	Chemical	MESH:D008550
28901737	531	535	mice	Species	10090
28901737	638	649	scopolamine	Chemical	MESH:D012601
28901737	664	700	impaired spatial learning and memory	Disease	MESH:D008569
28901737	725	734	melatonin	Chemical	MESH:D008550
28901737	811	822	scopolamine	Chemical	MESH:D012601
28901737	899	924	choline acetyltransferase	Gene	12647
28901737	926	930	ChAT	Gene	12647
28901737	968	971	CHT	Gene	63993
28901737	974	1009	vesicular acetylcholine transporter	Gene	20508
28901737	1011	1016	VAChT	Gene	20508
28901737	1023	1059	muscarinic acetylcholine receptor M1	Gene	12669
28901737	1061	1064	M1R	Gene	12669
28901737	1126	1135	melatonin	Chemical	MESH:D008550
28901737	1158	1162	ChAT	Gene	12647
28901737	1165	1168	CHT	Gene	63993
28901737	1171	1176	VAChT	Gene	20508
28901737	1183	1186	M1R	Gene	12669
28901737	1291	1300	melatonin	Chemical	MESH:D008550
28901737	1341	1359	cognitive deficits	Disease	MESH:D003072
28901737	1437	1442	mouse	Species	10090
28901737	1452	1463	scopolamine	Chemical	MESH:D012601
28901737	1472	1479	amnesia	Disease	MESH:D000647
28901737	Negative_Correlation	MESH:D012601	12669
28901737	Positive_Correlation	MESH:D008550	12669
28901737	Negative_Correlation	MESH:D012601	63993
28901737	Negative_Correlation	MESH:D012601	12647
28901737	Positive_Correlation	MESH:D008550	12647
28901737	Positive_Correlation	MESH:D012601	MESH:D008569
28901737	Negative_Correlation	MESH:D008550	MESH:C535672
28901737	Positive_Correlation	MESH:D008550	20508
28901737	Negative_Correlation	MESH:D012601	20508
28901737	Positive_Correlation	MESH:D012601	MESH:D000647
28901737	Negative_Correlation	MESH:D008550	MESH:D000647
28901737	Positive_Correlation	MESH:D008550	63993
28901737	Positive_Correlation	MESH:D012601	MESH:D003072
28901737	Association	MESH:D008550	MESH:D000544
28901737	Association	MESH:D008550	MESH:D003072
28901737	Negative_Correlation	MESH:D008550	MESH:D012601

